Dose-finding study of subcutaneously administered BI 456906 for 16 weeks, compared with placebo and open-label semaglutide in patients with type 2 diabetes mellitus
Egler had a BMI of 25 and shed 15 pounds over six weeks on a microdose protocol
Lawsuits filed allege that drug companies ignored significant evidence of these risks and continued to market these drugs as safe weight loss medications
Helps maintain healthy glucose and lipid levels
Explore GLP-1 medication options with licensed healthcare providers whom you may connect with via Edens platform
Why GLP-1 Medications Are Prescribed GLP-1 receptor agonists such as semaglutide (Wegovy) and liraglutide are approved for: Adults with a body mass index (BMI) of 30 or greater Adults with a BMI of 27 or greater with at least one weight-related condition such as hypertension, type 2 diabetes, or high cholesterol These medications mimic the GLP-1 hormone, which helps regulate appetite, glucose levels, and insulin secretion
